On 25 June 2001, Milorad Kmojelac, a Bosnian Serb, was indicted by the Prosecutor of the International Criminal Court for the Former Yugoslavia (ICTY) on twelve counts of crimes against humanity and violations of the laws and customs of war. He had served as the commander of the Foca Kazneno-Popravni Dom (“KP Dom”) concentration camp in Bosnia-Herzegovina from April 1992 to August 1993. The charges against Kmojelac were based upon his acting in “common purpose” (as defined by Articles 7(1) and 7(3) of the ICTY Statute) with the KP Dom guards in persecuting Muslim and other non-Serb civilian detainees through torture, beatings, and murder. The Trial Chamber convicted Kmojelac of several of the charged offenses and sentenced him to a total of 7 Vi years imprisonment. He was acquitted of counts of torture, murder, imprisonment, and other inhumane acts. Both the defense and the prosecution appealed on various grounds. The Appeals Chamber dismissed all defense appeals and found for the prosecution on several grounds, increasing Krnolejac's sentence to 15 years.

This case presents the question whether the Executive Branch may hold uncharged citizens of foreign nations in indefinite detention in territory under the "complete jurisdiction and control" of the United States while effectively denying them the right to challenge their detention in any tribunal anywhere, including the courts of the U.S. The issues we are required to confront are new, important, and difficult.

Having regard to paragraphs 1, 3 and 4 of Article IX of the Marrakesh Agreement Establishing the World Trade Organization ("the WTO Agreement");

Conducting the functions of the Ministerial Conference in the interval between meetings pursuant to paragraph 2 of Article IV of the WTO Agreement;

Noting the Declaration on the TRIPS Agreement and Public Health (WT/MIN(01)/DEC/2) (the "Declaration") and, in particular, the instruction of the Ministerial Conference to the Council for TRIPS contained in paragraph 6 of the Declaration to find an expeditious solution to the problem of the difficulties that WTO Members with insufficient or no manufacturing capacities in the pharmaceutical sector could face in making effective use of compulsory licensing under the TRIPS Agreement and to report to the General Council before the end of 2002;